Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Eisai Inc.

Clinical trials sponsored by Eisai Inc., explained in plain language.

Now part of Eisai Co., Ltd. ESAIY OTC

A pharmaceutical company focused on neurology and oncology, subsidiary of Eisai Co., Ltd.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 10 Completed 4 Terminated 1

Dravet syndrome drug trial halted early: did lorcaserin help?

Disease control Terminated

This study tested whether lorcaserin, when added to current medications, could reduce convulsive seizures in people with Dravet syndrome, a severe form of epilepsy. The trial planned to enroll about 22 participants aged 2 and older, but it was terminated early. The main goal was …

Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:53 UTC